Discontinued — last reported Q2 '16
Veradermics Tax receivable within other current assets decreased by 3.3% to $1.21M in Q1 2026 compared to the prior quarter.
An increase may indicate overpayment of estimated taxes or the realization of tax credits, while a decrease suggests the collection of these receivables or a shift in tax liability status.
This represents the amount of income tax overpayments or credits due to the company from tax authorities that are expect...
Common across all capital-intensive industries; peers typically report this within current assets or as a component of other receivables.
other_income_taxes_receivable| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.26M | $1.21M |
| QoQ Change | — | -3.3% |